Brace yourself for soaring drug spending costs — and feel free to blame Obamacare.

A HealthPocket study released Thursday finds that copayments and co-insurance fees for drugs increased an average of 34 percent under the Patient Protection and Affordable Care Act. And enrollees who use brand-name drugs and specialty drugs are getting hit much harder with rising costs.

That was the finding after researchers examined new PPACA health plans from 46 states and compared the prices to those from the pre-PPACA individual insurance market.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.